The intrapleural administration with thymic peptides in malignant pleural effusion: A clustered systematic review and meta-analysis

被引:1
|
作者
Wang, Cheng-Qiong [1 ,2 ]
Shen, You-Shu [4 ]
Chen, Xiao-Fan [3 ]
Jiang, Hong [1 ,2 ]
Yang, Xue-Mei [1 ,2 ]
Fan, Teng-Yang [2 ]
Li, Shu-Guang [2 ]
Yang, Ping [4 ]
Zhan, Lin [5 ]
Chen, Rong [6 ]
Feng, Ji-Hong [7 ]
Xiao, Xue [1 ,2 ]
Xiao, Zheng [1 ,2 ]
机构
[1] Zunyi Med Coll, Affiliated Hosp, Evidence Based Med Ctr, MOE Virtual Res Ctr Evidence Based Med, Zunyi 563003, Guizhou, Peoples R China
[2] Zunyi Med Univ, Dept Gen Practice, Affiliated Hosp, Zunyi 563003, Guizhou, Peoples R China
[3] Jiangxi Univ Tradit Chinese Med, Evidence Based Med Res Ctr, Nanchang 330004, Jiangxi, Peoples R China
[4] Zunyi Med Univ, Dept Infect Dis, Affiliated Hosp, Zunyi 563003, Guizhou, Peoples R China
[5] Guizhou Univ, Guizhou Prov Peoples Hosp, Lab Res Ctr, Guiyang 550002, Guizhou, Peoples R China
[6] Anshun Peoples Hosp, Dept Infect Dis, Anshun 561000, Guizhou, Peoples R China
[7] Wenzhou Med Univ, Lishui Peoples Hosp, Dept Oncol, Affiliated Hosp 6, Lishui, Zhejiang, Peoples R China
关键词
Malignant pleural effusion (MPE); Thymic peptides (TPs); Intrapleural administration; Chemical agents; Clustered systematic review; Meta-analysis; MANAGEMENT; CANCER; BLEOMYCIN;
D O I
10.1016/j.intimp.2022.108688
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Thymic peptides (TPs) are often used to control malignant pleural effusion (MPE). So, we performed a clustered systematic review and meta-analysis to clarify the treatment regimens of TPs for MPE, demonstrate their clinical effectiveness and safety, and reveal the indications and optimal usage for a desired effectiveness. Materials and methods: We collected all trials of TPs for MPE from Chinese and English databases (from inception until May 2021). After evaluating their bias risk, we pooled the data from each regimen using the meta-analysis or descriptive analysis, and summarized the evidence quality using the Grading of Recommendation Assessment, Development and Evaluation approach (GRADE). Results: Thirty-four trials were clustered into TPs for MPE from lung cancer or miscellaneous tumors. The TPs combined with chemical agents were mainly used in MPE from lung cancer. All five regimens, only thymosin with oxaliplatin (L-OHP) significantly improved the complete response (CR) [2.40 (1.84 to 3.13)], quality of life [2.04 (1.20 to 3.48)], 0.5- and 1-year overall survival (OS) rate [5.75 (3.02 to 10.92) and 5.29, (1.71 to 16.36)]. It also up-regulated the T lymphocyte levels, and reduced the pleurodesis failure, disease progression and adverse events. In patients with moderate to large volume, Karnofsky Performance Status score >= 50 or anticipated survival time >= 3 months, the thymosin (300 mg/time, one time/week and lasting two to eight times) with oxaliplatin (100 mg/m(2)) achieved a desired response. Most results were moderate quality. Conclusions: The current evidences indicate that the TPs are important pleurodesis agents, which combination with chemical agents are mainly used in MPE from lung cancer. The thymosin with L-OHP is a main regimen, which shows a significant improvement in clinical responses, antitumor immunity, and with a reasonable security. The evidence also provides indications and optimal usage for achieving a desired effectiveness.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma
    Cao, Christopher
    Tian, David
    Park, John
    Allan, James
    Pataky, Kristopher A.
    Yan, Tristan D.
    LUNG CANCER, 2014, 83 (02) : 240 - 245
  • [32] The diagnostic value of survivin in malignant pleural effusion: A meta-analysis
    Chen, Shi
    Wang, Yunfang
    An, Li
    Fei, Zhong-ting
    Li, Tian
    CLINICA CHIMICA ACTA, 2015, 441 : 142 - 147
  • [33] Indwelling Pleural Catheter (IPC) Versus Chemical Pleurodesis (CP) for the Management of Malignant Pleural Effusion (MPE): A Systematic Review and Meta-Analysis
    Velagapudi, R.
    Upadhaya, S.
    Kakazu, M. A. Tamae
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [34] Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma An updated meta-analysis
    Gao, Ruiyue
    Wang, Feng
    Wang, Zhen
    Wu, Yanbing
    Xu, Lili
    Qin, Yue
    Shi, Huanzhong
    Tong, Zhaohui
    MEDICINE, 2019, 98 (14)
  • [35] Surgery versus intrapleural fibrinolysis for management of complicated pleural infections: a systematic review and meta-analysis
    Chang, Jaewon
    Indja, Ben
    King, Jesse
    Chan, Stephanie
    Flynn, Campbell D.
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [36] Investigation on the efficiency of lentinan for injection combining cisplatin on treating malignant pleural effusion based on systematic review and meta-analysis
    Wang, Yixuan
    Wang, Haojia
    Chai, Keyan
    Guo, Siyu
    Gao, Yifei
    Li, Jiaqi
    Qiao, Chuanqi
    Yang, Siyun
    Zhou, Jiying
    Lin, Yifan
    Zhang, Xiaomeng
    Wu, Jiarui
    MEDICINE, 2024, 103 (21) : E38032
  • [37] Comparison of Efficacy and Safety of Talc to Povidone-Iodine Pleurodesis in Malignant Pleural Effusion: A Systematic Review and Meta-Analysis
    Balan, Divya
    Baral, Tejaswini
    Manu, Mohan K.
    Mohapatra, Aswini Kumar
    Miraj, Sonal Sekhar
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2025, 46 (01) : 24 - 30
  • [38] Unstimulated Pleural Fluid Interferon Gamma for Diagnosis of Tuberculous Pleural Effusion: a Systematic Review and Meta-analysis
    Aggarwal, Ashutosh Nath
    Agarwal, Ritesh
    Dhooria, Sahajal
    Prasad, Kuruswamy Thurai
    Sehgal, Inderpaul Singh
    Muthu, Valliappan
    JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (05)
  • [39] Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis
    Kassirian, Shayan
    Hinton, Stephanie N.
    Cuninghame, Sean
    Chaudhary, Rushil
    Iansavitchene, Alla
    Amjadi, Kayvan
    Dhaliwal, Inderdeep
    Zeman-Pocrnich, Cady
    Mitchell, Michael A.
    THORAX, 2023, 78 (01) : 32 - 40
  • [40] Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis
    Yeung, Maggie
    Loh, El-Wui
    Tiong, Tung-Yu
    Tam, Ka-Wai
    CLINICAL & EXPERIMENTAL METASTASIS, 2020, 37 (04) : 541 - 549